Biotech

All Articles

UK reveals plans to launch 18 brand new scientific trial centers

.In the middle of a yearslong medical test decline in the U.K., a brand new public-private collabora...

UPDATE: Genentech telegraphs 93 layoffs in California after sharing strategies to shutter cancer cells immunology study system

.Adhering to the announcement of a sizable layoff round in April and a major rebuilding project intr...

Neurocrine's KarXT competitor attacks in phase 2-- but simply at low dosage

.Neurocrine Biosciences has obtained its own hoped-for profile page in a phase 2 mental illness tria...

Vaderis' unusual blood vessel disorder drug reduces nosebleeds

.Vaderis Therapeutics' goal to develop the first drug intended specifically at a particular uncommon...

Navigator rears $100M to establish new autoimmune pipe

.Navigator Medicines has actually outfitted on its own along with $100 thousand in series A funds as...

Duality looks for cash money for ADC trials as IPO surge infects Asia

.China's Duplicity Biotherapeutics has filed (PDF) paperwork for a Hong Kong IPO, finding an unrevea...

YolTech markets China rights to genetics editing and enhancing treatment for $29M

.4 months after Mandarin gene editing and enhancing firm YolTech Rehabs took its own cholesterol lev...

Addex stock climbs after Indivior provides to $300M for material

.Indivior is actually picking up a tiny particle allosteric modulator created to address drug make u...

Molecular Allies changes AML trial over 'suboptimal visibility'

.Molecular Companions has identified "suboptimal exposure" to its tetra-specific T-cell engager as t...

Despite mixed market, a venture capital rebirth could be can be found in Europe: PitchBook

.While the biotech assets performance in Europe has slowed down rather complying with a COVID-19 bac...